Radiation field size and dose determine oncologic outcome in esophageal cancer. - Wikidata - wikimedia - TriplyDB

Radiation field size and dose determine oncologic outcome in esophageal cancer.

Radiation field size and dose determine oncologic outcome in esophageal cancer.

http://www.wikidata.org/entity/Q37340815

about

What is the optimal radiation dose for non-operable esophageal cancer? Dissecting the evidence in a meta-analysis.

P2860

Q47142547-BB377709-6A2B-4F90-9C21-CC898310AD78

P2860

Radiation field size and dose determine oncologic outcome in esophageal cancer.

http://www.wikidata.org/entity/Q37340815

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Radiation field size and dose determine oncologic outcome in esophageal cancer.

@en

Radiation field size and dose determine oncologic outcome in esophageal cancer.

@nl

type

label

Radiation field size and dose determine oncologic outcome in esophageal cancer.

@en

Radiation field size and dose determine oncologic outcome in esophageal cancer.

@nl

prefLabel

Radiation field size and dose determine oncologic outcome in esophageal cancer.

@en

Radiation field size and dose determine oncologic outcome in esophageal cancer.

@nl

P1433

Q37340815-45EE9789-A68C-40C2-BD20-7788E6986B81

P1476

Q37340815-ABF8E525-5503-489F-AC04-9DB2E52F815B

P2093

Q37340815-024D6A68-53F0-4AFB-A08D-BD949F0C5C17

Q37340815-1DECA0BB-CD5F-4277-8DDF-463AF132CBBA

Q37340815-4440EF70-3EB7-470F-AABB-E829B67403AA

Q37340815-CC6950B8-F598-47EA-876C-B73957D73C11

Q37340815-ED5732D0-E101-4EDE-9EDB-37E509C9947D

P2860

Q37340815-0814FFBA-E744-4103-A08D-169629D5C698

Q37340815-15EFCBE0-5C68-465E-A8C6-479925618613

Q37340815-2EDE6B80-2487-4B1A-918F-CE89CBD1DC69

Q37340815-3275FB8D-D7F1-4F5E-B877-7881DB397AB2

Q37340815-3551C600-5EA5-47F4-8EA8-42FF44F5CC35

Q37340815-3C5C9D23-29C1-42AA-B5D9-29B27EA7EB39

Q37340815-5D53C8E7-970F-448A-A22D-442742C77DF8

Q37340815-5D84E627-6B7F-4211-B0CC-ADB6B777FB81

Q37340815-615A85F1-FA84-4EDC-9ED8-F27BAD2E4224

Q37340815-61B0C48F-A198-45FA-BBD3-18144F442D23

P2888

Q37340815-A9E3A4EF-F9F0-4C44-972A-0865191BFD91

P304

Q37340815-6A678982-C0E8-4948-BE2D-4BADC98F342B

P31

Q37340815-F1C3ABF5-6251-4F35-95A0-5E28C122C1B9

P356

Q37340815-9238E9BF-E4A2-426B-899C-DC32F2290269

P433

Q37340815-86F82BD8-85B6-4135-8715-434A8AFBEC85

P478

Q37340815-73F9016A-F52A-4F2C-AC3E-E57875C5CECE

P577

Q37340815-4E968AC5-DB67-452F-A9B2-185BC401EED4

P6179

Q37340815-A13A0F41-24B4-43EB-A1F7-8232BB35638F

P698

Q37340815-4D1861BE-2D80-4F87-9B8B-724ED4CEDC6A

P932

Q37340815-50F43CE3-7863-46A6-8BC4-0CB31081F508

P356

S12957-016-1024-0

P1433

World Journal of Surgical Oncology

P1476

Radiation field size and dose determine oncologic outcome in esophageal cancer.

@en

P2093

Alpaslan Mayadagli

http://www.w3.org/2001/XMLSchema#string

Cengiz Gemici

http://www.w3.org/2001/XMLSchema#string

Gokhan Yaprak

http://www.w3.org/2001/XMLSchema#string

Hasan Fevzi Batirel

http://www.w3.org/2001/XMLSchema#string

Mahmut Ilhan

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative chemotherapy for resectable thoracic esophageal cancer

Preoperative chemotherapy for resectable thoracic esophageal cancer

Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the Society of Thoracic Surgeons database.

A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer.

Adjuvant chemotherapy versus surgery alone for esophageal squamous cell carcinoma: a meta-analysis of randomized controlled trials and nonrandomized studies.

Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications.

Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response.

Failure patterns in patients with esophageal cancer treated with definitive chemoradiation.

Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113

A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246.

P2888

s12957-016-1024-0

P304

263

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12957-016-1024-0

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1036500721

http://www.w3.org/2001/XMLSchema#string

P698

27737673

http://www.w3.org/2001/XMLSchema#string

P932

5064926

http://www.w3.org/2001/XMLSchema#string